Active surveillance

Active surveillance (watchful waiting) may be offered for stage II prostate cancer in certain situations. It may be offered to men with favourable (low) risk prostate cancer or to older men (over the age of 70) and men who have other health problems.

Hormonal therapy

Hormonal therapy may be offered for stage II prostate cancer to men who have intermediate-risk or high-risk prostate cancer that cannot be treated with radiation therapy or surgery.

Hormonal therapy drugs may be given before, during and after radiation therapy, for a period of 6 months to 3 years.